A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients
- 1 January 1996
- journal article
- clinical trial
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 20 (1), 57-71
- https://doi.org/10.1016/0278-5846(95)00292-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- FluoxetineNew England Journal of Medicine, 1994
- Long-Term Safety and Clinical Acceptability ofJournal of Clinical Psychopharmacology, 1994
- A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholiaInternational Clinical Psychopharmacology, 1994
- Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomesLife Sciences, 1993
- The Evidence for 20 mg a day of Fluoxetine as the Optimal Dose in the Treatment of DepressionThe British Journal of Psychiatry, 1988
- Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivativeBiochemical Pharmacology, 1986
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960